The University of Cambridge, new-immunotherapy-targets-revealed

New Cambridge accelerator for deeptech startups launches with five machine learning investments

Differing immune response found in asymptomatic and severe COVID cases

Pembroke plans approved

First study of Placenta genomic architecture

Full evolutionary journey of hospital superbug mapped for the first time

Cambridge spin-out Sorex Sensors completes £900k funding round

Intellegens receives Innovate UK funding to model COVID-19 using artificial intelligence

New immunotherapy targets revealed

Qkine closes £1.5 million series A investment round

Emmanuel plans approved

Cambridge-led study recommends dramatic changes to the way we interact with animals

National Centre for Propulsion and Power plans approved